How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4221, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to S.1355, the Pasteur Act; issues related to Hepatitis C funding.
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Issues related to diagnostic testing and Hepatitis C funding
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to Hepatitis C funding, issues related to pandemic preparedness.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4221, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to S.1355, the Pasteur Act; issues related to Hepatitis C funding.
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
2024 · second_quarter · Q2
Issues related to diagnostic testing and Hepatitis C funding
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to Hepatitis C funding, issues related to pandemic preparedness.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to Hepatitis C funding.
Issues related to diagnostic testing and Hepatitis C funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to diagnostic testing
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to diagnostic testing
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4421/S.2333, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to Hepatitis C funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to diagnostic testing
Issues related to diagnostic testing; issues related to Antimicrobial Resistance; issues related to H.R. 4221, the Pandemic All Hazards Preparedness Act (PAHPA) reauthorization; issues related to S.1355, the Pasteur Act; issues related to Hepatitis C funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office